MedPath

Ultrasound Study by Texturization as a Predictor of Pregnancy in Oocyte Donation Programs

Withdrawn
Conditions
Infertility
Interventions
Other: Ultrasound texturization
Registration Number
NCT03507322
Lead Sponsor
IVI Sevilla
Brief Summary

This study is focused on analysing the application of ultrasound scanning techniques as new biomarkers in reproductive medicine. Those biomarkers are based on the analysis of ultrasound texture in different areas of uterine tissue, using 2D/3D ultrasound scanning. Investigators will use the algorithm Text® to analyse the ultrasound texture of the endometrium and myometrium. The aim of the project is to study if it is possible to obtain measurable, objective and reproducible data in healthy volunteers which can be used to predict pregnancy and determine the best moment to perform embryo transfer in assisted reproductive technology (ART) cycles

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Body mass index (BMI) between 18 and 30 kg/m2
  • Not taking the contraceptive pill in a previous cycle
  • Non-pregnant: beta human chorionic gonadotropin (HCG) test with negative result at the beginning of the study)
  • No previous history of inflammatory diseases, circulatory diseases, abdomen or pelvic diseases
  • Physical gynecological exploration without pathological findings
  • Gynecological ultrasound study of the uterus with a normal result
Exclusion Criteria
  • Ultrasound studies with technical defects in image acquisition
  • Simultaneous participation in other studies
  • Previous participation in other study which can affect the results of the present study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Ultrasound texturizationUltrasound texturizationApplication of ultrasound texturization (2D/3D ultrasound scanning)
Primary Outcome Measures
NameTimeMethod
Chemical pregnancy rateAround 14 days after embryo transfer

Positive result in beta HCG test indicating pregnancy

Clinical miscarriage rateUp to 20 weeks after embryo transfer

Interruption of pregnancy after confirming clinical pregnancy using ultrasound scanning

beta HCG levelAround 14 days after embryo transfer

Level of beta HCG in the test performed to detect pregnancy

Clinical pregnancy rateAround 5-6 weeks after embryo transfer

Detection of gestational sac through ultrasound scanning indicating clinical pregnancy

Biochemical miscarriage rateUp to one month after embryo transfer

Interruption of pregnancy after a positive result in the beta HCG test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IVI Sevilla

🇪🇸

Sevilla, Spain

© Copyright 2025. All Rights Reserved by MedPath